BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22499344)

  • 1. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
    Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
    J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
    Hafner C; van Oers JM; Vogt T; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Hartmann A
    J Clin Invest; 2006 Aug; 116(8):2201-2207. PubMed ID: 16841094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis.
    Groesser L; Herschberger E; Landthaler M; Hafner C
    Br J Dermatol; 2012 Apr; 166(4):784-8. PubMed ID: 22188534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocytic epidermal nevi associated with localized fibro-osseous lesions without hypophosphatemia.
    Mestach L; Polubothu S; Calder A; Denayer E; Gholam K; Legius E; Levtchenko E; Van Laethem A; Brems H; Kinsler VA; Morren MA
    Pediatr Dermatol; 2020 Sep; 37(5):890-895. PubMed ID: 32662096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi.
    Gadea A; Hernández-Muñoz I; Vicente A; Andrades E; García-Calvente M; Camacho L; Fernandez-Rodríguez C; Bellosillo B; Pujol R; Toll A
    J Med Genet; 2020 Sep; 57(9):601-604. PubMed ID: 31937562
    [No Abstract]   [Full Text] [Related]  

  • 6. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23.
    Avitan-Hersh E; Tatur S; Indelman M; Gepstein V; Shreter R; Hershkovitz D; Brick R; Bergman R; Tiosano D
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E132-6. PubMed ID: 24243633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
    Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
    J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation.
    Bygum A; Fagerberg CR; Clemmensen OJ; Fiebig B; Hafner C
    BMC Med Genet; 2011 Jun; 12():79. PubMed ID: 21639936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Woolly hair nevus caused by somatic mutation and Costello syndrome caused by germline mutation in HRAS: Consider parental mosaicism in prenatal counseling.
    Liang J; Guo Y; Lu Z; Yu H; Wu L; Yao Z
    J Dermatol; 2022 Jan; 49(1):161-164. PubMed ID: 34601768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.
    Lim YH; Ovejero D; Derrick KM; ; Collins MT; Choate KA
    J Am Acad Dermatol; 2016 Aug; 75(2):420-7. PubMed ID: 27444071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic basis of seborrheic keratosis and epidermal nevi].
    Hafner C; Hafner H; Groesser L
    Pathologe; 2014 Sep; 35(5):413-23. PubMed ID: 25187080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
    Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
    Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality of basal cell carcinoma arising in an epidermal nevus. New insights provided by molecular analysis.
    Hafner C; Klein A; Landthaler M; Vogt T
    Dermatology; 2009; 218(3):278-81. PubMed ID: 19122450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum.
    Shen AS; Peterhof E; Kind P; Rütten A; Zelger B; Landthaler M; Berneburg M; Hafner C; Groesser L
    Hum Pathol; 2015 Feb; 46(2):272-6. PubMed ID: 25532942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
    Hernández S; Toll A; Baselga E; Ribé A; Azua-Romeo J; Pujol RM; Real FX
    J Invest Dermatol; 2007 Jul; 127(7):1664-6. PubMed ID: 17255960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
    Hafner C; Vogt T; Landthaler M; Müsebeck J
    Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra.
    Hafner C; Landthaler M; Mentzel T; Vogt T
    Br J Dermatol; 2010 Mar; 162(3):508-12. PubMed ID: 19845664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo.
    Hafner C; Stoehr R; van Oers JM; Zwarthoff EC; Hofstaedter F; Landthaler M; Hartmann A; Vogt T
    Br J Dermatol; 2009 Mar; 160(3):546-51. PubMed ID: 19076977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naevus sebaceus: a mosaic RASopathy.
    Aslam A; Salam A; Griffiths CE; McGrath JA
    Clin Exp Dermatol; 2014 Jan; 39(1):1-6. PubMed ID: 24341474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.